This U.K. firm chalked up the biggest hedge-fund profit ever last year
Big bets on defence and infrastructure spending helped lift TCI's annual return to 27%. The biggest hedge funds are proving themselves the best hedge funds...
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
Bitcoin bulls avoided a correction as US markets opened, but analysis warned that Strategy was responsible for much of the latest BTC price strength.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse ArticlesBig bets on defence and infrastructure spending helped lift TCI's annual return to 27%. The biggest hedge funds are proving themselves the best hedge funds...
Insider trading is hard to curb on non-KYC prediction markets, but even identity checks do not fully eliminate abuse, according to MessariâEUR(TM)s Austin...
"He has included a provision stating that I would be responsible for 'maintenance and expenses' during my occupancy."
Bitcoin bulls defend $90,000 as Hash Ribbons and Fear and Greed Index flash buy signals, hinting at a potential rally ahead despite recent pressures.
Marks & Spencer CTO Josie Smith departs following costly cyberattack
Novartis CEO says U.S. manufacturing expansion will shield from tariffs
Risk assets slide amid tariff uncertainty and rising global bond yields.
Goldman Sachs cuts SKF to sell, sees 5% downside to SEK 237
U.S. stock futures slump as Greenland row weighs; DJIA seen down 750 points
The funding will enable mass production of RNGD chips, expand global operations, and develop a third-generation chip.
The stakes seem higher this time around, but the playbook is eerily similar.
The growing scourge of food allergies drove U.K. heavyweight GSK to announce a $2.2 billion deal on Tuesday.